SCHW vs VYNE · P/E 19, rev $13.55B vs rev $501.0K
Charles Schwab Corp (SCHW) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
Charles Schwab Corp (SCHW) is a capital markets company listed on NYSE. It is led by Richard Andrew Wurster C.F.A., CMT.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported SCHW revenue for 2026-06-30 was $13.55B. Net income was $5.28B. SCHW currently screens at market cap $164.37B and trailing P/E 18.8.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
SCHW currently screens at market cap $164.37B and trailing P/E 18.8. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the SCHW and VYNE stock pages for the full models.
Not investment advice.